NYLIM
ADTN icon

New York Life Investment Management’s Adtran ADTN Stock Holding History

New York Life Investment Management’s Portfolio ADTN Stock Details ADTN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-21,548
Closed -$158K – 1330
2023
Q4 		$158K Sell
21,548
-901
-4% -$5.94K ﹤0.01% 1300
2023
Q3 		$185K Sell
22,449
-3,537
-14% -$31.4K ﹤0.01% 1279
2023
Q2 		$274K Sell
25,986
-4,200
-14% -$41.7K ﹤0.01% 1261
2023
Q1 		$479K Buy
+30,186
New +$524K 0.01% 925

Other funds holding ADTN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCM
Divisar Capital Management San Francisco, California $392M AUM 108.45% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
DnB Asset Management
DnB Asset Management Oslo, Norway $28B AUM 26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

New York Life Investment Management's ADTN Position: Q1 2024 in Review

New York Life Investment Management sold out of Adtran (ADTN) in Q1 2024, closing a stake of 21,548 shares — an estimated $158K sold.

New York Life Investment Management first reported a position in ADTN in Q1 2023 and held it in 4 quarters. The position peaked at $479K in Q1 2023. 169 funds tracked by Wall St. Rank hold ADTN as of Q1 2024.

  • New York Life Investment Management reported no remaining Adtran position as of Q1 2024 after selling out during the quarter.
  • New York Life Investment Management sold 21,548 Adtran shares in Q1 2024, an estimated $158K.
  • New York Life Investment Management first reported a position in Adtran in Q1 2023 and held it in 4 quarters.
  • New York Life Investment Management's Adtran position peaked at $479K in Q1 2023.
  • 169 funds tracked by Wall St. Rank held Adtran as of Q1 2024.

Based on New York Life Investment Management's 13F filing for Q1 2024, filed 6 May 2024.